Literature DB >> 28075092

Diabetes Mellitus: Management of Gastrointestinal Complications.

Beth Careyva1, Brian Stello1.   

Abstract

Gastrointestinal disorders are common complications of diabetes mellitus and include gastroparesis, nonalcoholic fatty liver disease, gastroesophageal reflux disease, and chronic diarrhea. Symptoms of gastroparesis include early satiety, postprandial fullness, nausea, vomiting of undigested food, bloating, and abdominal pain. Gastroparesis is diagnosed based on clinical symptoms and a delay in gastric emptying in the absence of mechanical obstruction. Gastric emptying scintigraphy is the preferred diagnostic test. Treatment involves glucose control, dietary changes, and prokinetic medications when needed. Nonalcoholic fatty liver disease and its more severe variant, nonalcoholic steatohepatitis, are becoming increasingly prevalent in persons with diabetes. Screening for nonalcoholic fatty liver disease is not recommended, and most cases are diagnosed when steatosis is found incidentally on imaging or from liver function testing followed by diagnostic ultrasonography. Liver biopsy is the preferred diagnostic test for nonalcoholic steatohepatitis. Clinical scoring systems are being developed that, when used in conjunction with less invasive imaging, can more accurately predict which patients have severe fibrosis requiring biopsy. Treatment of nonalcoholic fatty liver disease involves weight loss and improved glycemic control; no medications have been approved for treatment of this condition. Diabetes is also a risk factor for gastroesophageal reflux disease. Patients may be asymptomatic or present with atypical symptoms, including globus sensation and dysphagia. Diabetes also may exacerbate hepatitis C and pancreatitis, resulting in more severe complications. Glycemic control improves or reverses most gastrointestinal complications of diabetes.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28075092

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  8 in total

Review 1.  Diabetes and the Esophagus.

Authors:  Roberto Monreal-Robles; José M Remes-Troche
Journal:  Curr Treat Options Gastroenterol       Date:  2017-12

2.  Improvement of continuous subcutaneous insulin infusion on patients with type 2 diabetes mellitus by 3-dimensional speckle tracking echocardiography.

Authors:  Hong-Xia Luo; Xiao-Ling Zhou; Hong-Ju Kou; Xian-Wei Ni; Qing Wu; Chun-Peng Zou; Dao-Zhu Wu; Yong-Fang Liu
Journal:  Int J Cardiovasc Imaging       Date:  2017-09-21       Impact factor: 2.357

3.  Association between alcohol consumption pattern and the incidence risk of type 2 diabetes in Korean men: A 12-years follow-up study.

Authors:  Dae-Yeon Lee; Min-Gyu Yoo; Hyo-Jin Kim; Han Byul Jang; Jae-Hong Kim; Hye-Ja Lee; Sang Ick Park
Journal:  Sci Rep       Date:  2017-08-04       Impact factor: 4.379

Review 4.  Diabetic autonomic neuropathy of the gastrointestinal tract.

Authors:  Edwin Kuźnik; Robert Dudkowiak; Rajmund Adamiec; Elżbieta Poniewierka
Journal:  Prz Gastroenterol       Date:  2020-06-08

5.  Analysis of Pepsin Concentration and Influencing Factors in Saliva of Elderly Nasal Feeding Patients.

Authors:  Yu Ding; Huiru Hou; Miao Liu; Xiaoyuan Wang; Yue Xu; Haiyan Shi; Haitao Du; Liyuan Wang
Journal:  Biomed Res Int       Date:  2021-01-25       Impact factor: 3.411

6.  The Association Between Proton Pump Inhibitors and COVID-19 is Confounded by Hyperglycemia in a Population-Based Study.

Authors:  Asher Shafrir; Ariel A Benson; Lior H Katz; Tiberiu Hershcovici; Menachem Bitan; Ora Paltiel; Ronit Calderon-Margalit; Rifaat Safadi; Michal Shauly-Aharonov
Journal:  Front Pharmacol       Date:  2022-02-04       Impact factor: 5.810

7.  Abnormal expressions of AGEs, TGF-β1, BDNF and their receptors in diabetic rat colon-Associations with colonic morphometric and biomechanical remodeling.

Authors:  Hong Sha; Xiaolin Tong; Jingbo Zhao
Journal:  Sci Rep       Date:  2018-06-21       Impact factor: 4.379

8.  Association between small intestinal bacterial overgrowth and beta-cell function of type 2 diabetes.

Authors:  Li-Hui Yan; Biao Mu; Da Pan; Ya-Nan Shi; Ji-Hong Yuan; Yue Guan; Wang Li; Xiao-Yi Zhu; Lei Guo
Journal:  J Int Med Res       Date:  2020-07       Impact factor: 1.671

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.